Baltes et al. showed that ITGB1, upon binding to collagen type 1, activates the ABC efflux transporter and exerts chemoresistance in doxorubicin, cisplatin, and mitoxantrone-treated breast cancer [76]. The gene discussed is ITGB1; the disease is breast carcinoma.